Key facts
- It has raised $5.6M; the latest was Early Stage VC ($5.6M) in Oct 2025.
- Notable investors include Puhua Capital, Wuxi Capital, National Innovation Center for Advanced Medical Devices.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for PulseHealth
- ·The full record, as it builds
Funding rounds
No funding rounds for PulseHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PulseHealth
Developer of a pan-cardiac and vascular life-cycle support platform designed to provide assistance and protection from pre-hospital emergency care through clinical intervention. The company offers pulsatile biomimetic intracardiac ventricular assist technology and an aortic occlusion balloon device, enabling cardiac and vascular clinicians to deliver more physiologic support and improved patient management.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2023
- Employees
- 40
- Website
- mcsmed.cn/
- Ownership
- Privately Held (backing)
PulseHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PulseHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PulseHealth in its N-PORT filings yet. We sweep new filings monthly.